欢迎您加入月均活跃用户100万＋的科研社区！如您有任何系统建议，请；如有合作推广需求，请点此洽谈。
| 近期推荐： | 热 SCI论文AI润色+人工QC服务 | 热 同行专家帮助选刊 | 热 Springer Nature特刊征稿 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | CANCER CANCER-AM CANCER SOC （此期刊被最新的JCR期刊SCIE收录） LetPub评分 8.0
56人评分
我要评分
声誉 8.8 影响力 7.3 速度 7.8 | |||||||||||||||||||||
| 期刊ISSN | 0008-543X | 
蝌蝌APP，让您与同行交流更轻松
 立即下载 | ||||||||||||||||||||
| E-ISSN | 1097-0142 | |||||||||||||||||||||
| 2024-2025最新影响因子 （数据来源于搜索引擎） | 5.1 点击查看影响因子趋势图 | |||||||||||||||||||||
| 实时影响因子 | 截止2025年5月19日：5.041 | |||||||||||||||||||||
| 2024-2025自引率 | 2.00%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年影响因子 | 6.3 | |||||||||||||||||||||
| JCI期刊引文指标 | 1.2 | |||||||||||||||||||||
| h-index | 277 | |||||||||||||||||||||
| CiteScore （ 2025年最新版） |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0142 | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | https://mc.manuscriptcentral.com/cancer | |||||||||||||||||||||
| 期刊语言要求 | Language Manuscripts must be written in American English and be grammatically and linguistically correct. Authors should seek assistance with style, grammar and vocabulary if necessary. Your manuscript may also be sent back to you for revision if the quality of English language is poor. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足CANCER的语言要求，还能让CANCER编辑和审稿人得到更好的审稿体验，让稿件最大限度地被CANCER编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||
| 通讯方式 | JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, USA, NJ, 07030 | |||||||||||||||||||||
| 出版商 | John Wiley and Sons Inc. | |||||||||||||||||||||
| 涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Semimonthly | |||||||||||||||||||||
| 出版年份 | 0 | |||||||||||||||||||||
| 年文章数 | 300点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 29.00% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 92.67% | |||||||||||||||||||||
| WOS期刊SCI分区 （ 2024-2025年最新版） | WOS分区等级：1区
| |||||||||||||||||||||
| 中国科学院《国际期刊预警 名单（试行）》名单 | 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
| 中国科学院SCI期刊分区 （ 2025年3月最新升级版） | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||
| 中国科学院SCI期刊分区 （ 2023年12月升级版） |
| |||||||||||||||||||||
| 中国科学院SCI期刊分区 （ 2022年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0008-543X%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 很快,2-3周 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 较易 | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在CANCER顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Mental disorders and mortality in cancer survivors: Key unaddressed factors Author: Li, Sheng; Ge, Zuyin Journal: CANCER. 2025; Vol. 131, Issue 8, pp. -. DOI: 10.1002/cncr.35837 PubMed DOI |
| 2. | Serum of interleukin-6 and procalcitonin as early diagnostic markers for the identification of poor hematopoietic reconstitution following allogeneic hematopoietic stem cell transplantation Author: Peng, Xiru; Jing, Xiaorui; Li, Ting; Cheng, Juan Journal: CANCER. 2025; Vol. 131, Issue 7, pp. -. DOI: 10.1002/cncr.35835 PubMed DOI |
| 3. | Perioperative chemotherapy for gastric cancer patients with microsatellite instability or deficient mismatch repair: A systematic review and meta-analysis Author: Liu, Baike; Shen, Chaoyong; Yin, Xiaonan; Jiang, Tianxiang; Han, Yihui; Yuan, Ruiwan; Yin, Yuan; Cai, Zhaolun; Zhang, Bo Journal: CANCER. 2025; Vol. 131, Issue 7, pp. -. DOI: 10.1002/cncr.35831 PubMed DOI |
| 4. | Burden of female-specific cancers in China from 1990 to 2021: A systematic analysis for the Global Burden of Disease Study 2021 Author: Ren, Wenhui; Guo, Xiangyu; Liu, Zheng; Wu, Yanqiu; Peng, Rui; Liu, Huixin; Qi, Jinlei Journal: CANCER. 2025; Vol. 131, Issue 2, pp. -. DOI: 10.1002/cncr.35712 PubMed DOI |
| 5. | Molecular measurable residual disease before transplantation independently predicts survival and relapse risk in adult lysine methyltransferase 2a-rearranged acute myeloid leukemia Author: Wang, Lulu; Chen, Yuxiu; Zang, Mengtong; Zhou, Jianying; Xiao, Mengyu; Fu, Haixia; Mo, Xiaodong; Wang, Fengrong; Han, Wei; Zhang, Yuanyuan; Yan, Chenhua; Wang, Zhidong; Han, Tingting; Lv, Meng; Chen, Huan; Chen, Yuhong; Chen, Yao; Wang, Jingzhi; Wang, Yu; Xu, Lanping; Liu, Kaiyan; Huang, Xiaojun; Zhang, Xiaohui Journal: CANCER. 2025; Vol. 131, Issue 2, pp. -. DOI: 10.1002/cncr.35717 PubMed DOI |
| 6. | Liposomal mitoxantrone monotherapy in patients with relapsed or refractory mature T-cell and natural killer-cell neoplasms: A phase 2, multicenter, open-label, single-arm trial Author: Gao, Yan; Huang, Yunhong; Zhang, Qingyuan; Yang, Haiyan; Li, Yufu; Li, Yan; Zhou, Min; Yang, Runxiang; Xu, Bing; Liu, Lihong; Yang, Yu; Peng, Zhigang; Yu, Ding; Zhou, Hui; Zhang, Rongyan; Zhang, Huilai; Qi, Junyuan; Xi, Yaming; Xing, Xiaojing; Wang, Zhao; Jing, Hongmei; Shuang, Yuerong; Zhang, Xiaohong; Ma, Liping; Jin, Hongyan; Lin, Li'e; Li, Chunlei; Xue, Jianfei; Liu, Yanping; Yuan, Jing; Huang, Huiqiang Journal: CANCER. 2025; Vol. 131, Issue 1, pp. -. DOI: 10.1002/cncr.35672 PubMed DOI |
| 7. | Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study Author: Lloret-Madrid, Pilar; Boluda, Blanca; Martinez-Lopez, Joaquin; Bergua, Juan; Rodriguez Arboli, Eduardo; Labrador, Jorge; Sossa, Claudia; Gil, Cristina; Algarra, Lorenzo; Lavilla-Rubira, Esperanza; Serrano, Josefina; de Rueda, Beatriz; Ibanez, Francisco; Gonzalez, Bernardo J. Gonzalez; Amigo, Maria Luz; Garcia Belmonte, Daniel; Rodriguez-Medina, Carlos; Gomez-Roncero, Maria I.; Colorado, Mercedes; Lopez Lorenzo, Jose L.; Tormo, Mar; Fernandez, Olga Arce; Cano-Ferri, Isabel; Solana-Altabella, Antonio; Foncillas, Maria-Angeles; Alfonso Pierola, Ana; Vives, Susana; Nunez, Marta Valero; Lopez-Vidal, Hernan; Perez-Santaolalla, Esther; Hermosin Ramos, Lourdes; Garcia Boyero, Raimundo; Gonzalez, Laura Llorente; Roldan, Alicia; Calderon, Soledad Casado; Infante, Joana Brioso; Olave, Teresa; Garcia-Suarez, Julio; de Laiglesia, Almudena; Rodriguez-Veiga, Rebeca; Trigo, Fernanda; Martinez-Cuadron, David; Montesinos, Pau Journal: CANCER. 2025; Vol. 131, Issue 1, pp. -. DOI: 10.1002/cncr.35696 PubMed DOI |
| 8. | Efficacy, safety, and pharmacokinetics of teclistamab in Chinese patients with relapsed/refractory multiple myeloma from the China cohort of MajesTEC-1 Author: Cai, Zhen; Xia, Zhongjun; He, Ai-Li; Dong, Yu-Jun; Wang, Yafei; Liao, Aijun; Song, Yang; Song, Juanjuan; Uhlar, Clarissa; Chastain, Katherine; Watkins, Latisha; Luo, Xinchao; Huang, Lin; Niu, Zhuolu; Carde, Natalia A. Quijano; Guo, Yue; Xu, Hongmei; Verona, Raluca I.; Zhou, Longen; Li, Jingyun; Fu, Weijun; Niu, Ting; Du, Juan Journal: CANCER. 2025; Vol. 131, Issue 1, pp. -. DOI: 10.1002/cncr.35665 PubMed DOI |
| 9. | Zanubrutinib plus R-CHOP for the treatment of newly diagnosed double-expressor lymphoma: A phase 2 clinical study Author: Yin, Xia; He, Qiang; Liu, Dan; Xie, Linna; Wang, Hui; Chen, Chunyan; Zhao, Chuanli; Shan, Ningning; Shi, Shanshan; Wei, Haichen; Ma, Ji; Lu, Ke; Wang, Liang; Wang, Yan; Xing, Lijie; Li, Zengjun Journal: CANCER. 2025; Vol. 131, Issue 1, pp. -. DOI: 10.1002/cncr.35697 PubMed DOI |
|
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2025 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
